Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

JAK3 Variant, Immune Signatures, DNA Methylation, and Social Determinants Linked to Survival Racial Disparities in Head and Neck Cancer Patients.

Guerrero-Preston R, Lawson F, Rodriguez-Torres S, Noordhuis MG, Pirini F, Manuel L, Valle BL, Hadar T, Rivera B, Folawiyo O, Baez A, Marchionni L, Koch WM, Westra WH, Kim YJ, Eshleman JR, Sidransky D.

Cancer Prev Res (Phila). 2019 Apr;12(4):255-270. doi: 10.1158/1940-6207.CAPR-17-0356. Epub 2019 Feb 18.

PMID:
30777857
2.

African head and neck fellowships: A model for a sustainable impact on head and neck cancer care in developing countries.

Fagan JJ, Otiti J, Aswani J, Konney A, Diom ES, Baidoo K, Onakoya PA, Mugabo RM, Noah P, Mashamba V, Kundiona I, Garba M, Biadgelign MG, Macharia C, Bogale M, Koch WM.

Head Neck. 2019 Jun;41(6):1824-1829. doi: 10.1002/hed.25615. Epub 2019 Jan 16.

PMID:
30652381
3.

Priorities, concerns, and regret among patients with head and neck cancer.

Windon MJ, D'Souza G, Faraji F, Troy T, Koch WM, Gourin CG, Kiess AP, Pitman KT, Eisele DW, Fakhry C.

Cancer. 2019 Apr 15;125(8):1281-1289. doi: 10.1002/cncr.31920. Epub 2019 Jan 15.

PMID:
30645761
4.

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma.

Califano JA, Khan Z, Noonan KA, Rudraraju L, Zhang Z, Wang H, Goodman S, Gourin CG, Ha PK, Fakhry C, Saunders J, Levine M, Tang M, Neuner G, Richmon JD, Blanco R, Agrawal N, Koch WM, Marur S, Weed DT, Serafini P, Borrello I.

Clin Cancer Res. 2018 Dec 1;24(23):6100. doi: 10.1158/1078-0432.CCR-18-3298. No abstract available.

PMID:
30510089
5.

Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma.

Kelley DZ, Flam EL, Guo T, Danilova LV, Zamuner FT, Bohrson C, Considine M, Windsor EJ, Bishop JA, Zhang C, Koch WM, Sidransky D, Westra WH, Chung CH, Califano JA, Wheelan S, Favorov AV, Florea L, Fertig EJ, Gaykalova DA.

Transl Res. 2018 Dec;202:109-119. doi: 10.1016/j.trsl.2018.07.007. Epub 2018 Jul 26.

PMID:
30118659
6.

HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.

Rettig EM, Bishop JA, Agrawal N, Chung CH, Sharma R, Zamuner F, Li RJ, Koch WM, Califano JA, Guo T, Gaykalova DA, Fakhry C.

Oral Oncol. 2018 Jul;82:168-175. doi: 10.1016/j.oraloncology.2018.05.017. Epub 2018 Jun 1.

PMID:
29909892
7.

Short- and long-term outcomes of oropharyngeal cancer care in the elderly.

Motz K, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Eisele DW, Koch WM, Frick KD, Gourin CG.

Laryngoscope. 2018 Sep;128(9):2084-2093. doi: 10.1002/lary.27153. Epub 2018 Mar 24.

PMID:
29573418
8.

Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy.

Rettig EM, Fakhry C, Hales RK, Kisuule F, Quon H, Kiess AP, Yin LX, Zhang Y, Blackford AL, Drummond MB, Gourin CG, Koch WM, Eisele DW, D'Souza G.

Head Neck. 2018 Jul;40(7):1534-1547. doi: 10.1002/hed.25148. Epub 2018 Mar 15.

PMID:
29542262
9.

Quality indicators of oropharyngeal cancer care in the elderly.

Gourin CG, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Koch WM, Eisele DW, Frick KD.

Laryngoscope. 2018 Oct;128(10):2312-2319. doi: 10.1002/lary.27050. Epub 2017 Dec 15.

PMID:
29243261
10.

Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks.

Kelley DZ, Flam EL, Izumchenko E, Danilova LV, Wulf HA, Guo T, Singman DA, Afsari B, Skaist AM, Considine M, Welch JA, Stavrovskaya E, Bishop JA, Westra WH, Khan Z, Koch WM, Sidransky D, Wheelan SJ, Califano JA, Favorov AV, Fertig EJ, Gaykalova DA.

Cancer Res. 2017 Dec 1;77(23):6538-6550. doi: 10.1158/0008-5472.CAN-17-0833. Epub 2017 Sep 25.

11.

Utility of preoperative fine needle aspiration in parotid lesions.

Eytan DF, Yin LX, Maleki Z, Koch WM, Tufano RP, Eisele DW, Boahene KDO, Fakhry C, Bishop JA, Westra WH, Gourin CG.

Laryngoscope. 2018 Feb;128(2):398-402. doi: 10.1002/lary.26776. Epub 2017 Aug 7.

PMID:
28782105
12.

Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC.

Gaykalova DA, Zizkova V, Guo T, Tiscareno I, Wei Y, Vatapalli R, Hennessey PT, Ahn J, Danilova L, Khan Z, Bishop JA, Gutkind JS, Koch WM, Westra WH, Fertig EJ, Ochs MF, Califano JA.

Oncotarget. 2017 Feb 28;8(9):15349-15363. doi: 10.18632/oncotarget.14856.

13.

Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.

Malm IJ, Fan CJ, Yin LX, Li DX, Koch WM, Gourin CG, Pitman KT, Richmon JD, Westra WH, Kang H, Quon H, Eisele DW, Fakhry C.

Cancer. 2017 May 15;123(10):1768-1777. doi: 10.1002/cncr.30512. Epub 2017 Jan 5.

14.

Assessment of the Predictive Value of the Modified Frailty Index for Clavien-Dindo Grade IV Critical Care Complications in Major Head and Neck Cancer Operations.

Abt NB, Richmon JD, Koch WM, Eisele DW, Agrawal N.

JAMA Otolaryngol Head Neck Surg. 2016 Jul 1;142(7):658-64. doi: 10.1001/jamaoto.2016.0707.

PMID:
27258927
15.

Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.

Rettig EM, D'Souza G, Thompson CB, Koch WM, Eisele DW, Fakhry C.

Cancer. 2016 Jun 15;122(12):1861-70. doi: 10.1002/cncr.30005. Epub 2016 May 16.

16.

Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.

Guo T, Gaykalova DA, Considine M, Wheelan S, Pallavajjala A, Bishop JA, Westra WH, Ideker T, Koch WM, Khan Z, Fertig EJ, Califano JA.

Int J Cancer. 2016 Jul 15;139(2):373-82. doi: 10.1002/ijc.30081. Epub 2016 Mar 30.

17.

Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.

Fakhry C, Qualliotine JR, Zhang Z, Agrawal N, Gaykalova DA, Bishop JA, Subramaniam RM, Koch WM, Chung CH, Eisele DW, Califano J, Viscidi RP.

Cancer Prev Res (Phila). 2016 Feb;9(2):135-41. doi: 10.1158/1940-6207.CAPR-15-0299. Epub 2015 Dec 23.

18.

Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients.

Gaykalova DA, Vatapalli R, Wei Y, Tsai HL, Wang H, Zhang C, Hennessey PT, Guo T, Tan M, Li R, Ahn J, Khan Z, Westra WH, Bishop JA, Zaboli D, Koch WM, Khan T, Ochs MF, Califano JA.

PLoS One. 2015 Nov 6;10(11):e0142148. doi: 10.1371/journal.pone.0142148. eCollection 2015.

19.

The Cost of Hospice Services in Terminally Ill Patients With Head and Neck Cancer.

Enomoto LM, Schaefer EW, Goldenberg D, Mackley H, Koch WM, Hollenbeak CS.

JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1066-74. doi: 10.1001/jamaoto.2015.2162.

PMID:
26447873
20.

Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.

Hayashi M, Guerrero-Preston R, Sidransky D, Koch WM.

Cancer Prev Res (Phila). 2015 Nov;8(11):1017-26. doi: 10.1158/1940-6207.CAPR-15-0180. Epub 2015 Aug 24.

21.

Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.

Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, James N, Rettig EM, Guo T, Pickering CR, Bishop JA, Chung CH, Califano JA, Eisele DW, Fakhry C, Gourin CG, Ha PK, Kang H, Kiess A, Koch WM, Myers JN, Quon H, Richmon JD, Sidransky D, Tufano RP, Westra WH, Bettegowda C, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Agrawal N.

Sci Transl Med. 2015 Jun 24;7(293):293ra104. doi: 10.1126/scitranslmed.aaa8507.

22.

Milk derived colloid as a novel drug delivery carrier for breast cancer.

Hayashi M, Silanikove N, Chang X, Ravi R, Pham V, Baia G, Paz K, Brait M, Koch WM, Sidransky D.

Cancer Biol Ther. 2015;16(8):1184-93. doi: 10.1080/15384047.2015.1056416. Erratum in: Cancer Biol Ther. 2015;16(10):1567.

23.

NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.

Gaykalova DA, Manola JB, Ozawa H, Zizkova V, Morton K, Bishop JA, Sharma R, Zhang C, Michailidi C, Considine M, Tan M, Fertig EJ, Hennessey PT, Ahn J, Koch WM, Westra WH, Khan Z, Chung CH, Ochs MF, Califano JA.

Int J Cancer. 2015 Oct 15;137(8):1879-89. doi: 10.1002/ijc.29558. Epub 2015 Jun 23.

24.

Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.

Hayashi M, Wu G, Roh JL, Chang X, Li X, Ahn J, Goldsmith M, Khan Z, Bishop J, Zhang Z, Zhou XC, Richmon J, Agrawal N, Koch WM.

Cancer. 2015 Jun 15;121(12):1957-65. doi: 10.1002/cncr.29303. Epub 2015 Mar 13.

25.

Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.

Califano JA, Khan Z, Noonan KA, Rudraraju L, Zhang Z, Wang H, Goodman S, Gourin CG, Ha PK, Fakhry C, Saunders J, Levine M, Tang M, Neuner G, Richmon JD, Blanco R, Agrawal N, Koch WM, Marur S, Weed DT, Serafini P, Borrello I.

Clin Cancer Res. 2015 Jan 1;21(1):30-8. doi: 10.1158/1078-0432.CCR-14-1716. Erratum in: Clin Cancer Res. 2018 Dec 1;24(23):6100.

26.

Intraoperative hypertensive crisis due to a catecholamine-secreting esthesioneuroblastoma.

Salmasi V, Schiavi A, Binder ZA, Ruzevick J, Orr BA, Burger PC, Ball DW, Blitz AM, Koch WM, Ishii M, Gallia GL.

Head Neck. 2015 Jun;37(6):E74-80. doi: 10.1002/hed.23907. Epub 2015 Apr 6. Review.

27.

Predicting survival in head and neck squamous cell carcinoma from TP53 mutation.

Masica DL, Li S, Douville C, Manola J, Ferris RL, Burtness B, Forastiere AA, Koch WM, Chung CH, Karchin R.

Hum Genet. 2015 May;134(5):497-507. doi: 10.1007/s00439-014-1470-0. Epub 2014 Aug 10.

28.

Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.

Ahn SM, Chan JY, Zhang Z, Wang H, Khan Z, Bishop JA, Westra W, Koch WM, Califano JA.

JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):846-54. doi: 10.1001/jamaoto.2014.1338.

29.

Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke.

Li R, Faden DL, Fakhry C, Langelier C, Jiao Y, Wang Y, Wilkerson MD, Pedamallu CS, Old M, Lang J, Loyo M, Ahn SM, Tan M, Gooi Z, Chan J, Richmon J, Wood LD, Hruban RH, Bishop J, Westra WH, Chung CH, Califano J, Gourin CG, Bettegowda C, Meyerson M, Papadopoulos N, Kinzler KW, Vogelstein B, DeRisi JL, Koch WM, Agrawal N.

Head Neck. 2015 Nov;37(11):1642-9. doi: 10.1002/hed.23807. Epub 2014 Aug 23.

30.

Novel insight into mutational landscape of head and neck squamous cell carcinoma.

Gaykalova DA, Mambo E, Choudhary A, Houghton J, Buddavarapu K, Sanford T, Darden W, Adai A, Hadd A, Latham G, Danilova LV, Bishop J, Li RJ, Westra WH, Hennessey P, Koch WM, Ochs MF, Califano JA, Sun W.

PLoS One. 2014 Mar 25;9(3):e93102. doi: 10.1371/journal.pone.0093102. eCollection 2014.

31.

Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay.

Smith DF, Maleki Z, Coughlan D, Gooi Z, Akpeng B, Ogawa T, Bishop JA, Frick KD, Agrawal N, Gourin CG, Ha PK, Koch WM, Richmon JD, Westra WH, Pai SI.

Oral Oncol. 2014 Jun;50(6):600-4. doi: 10.1016/j.oraloncology.2014.02.011. Epub 2014 Mar 12.

32.

Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue.

Poling JS, Ma XJ, Bui S, Luo Y, Li R, Koch WM, Westra WH.

Oral Oncol. 2014 Apr;50(4):306-10. doi: 10.1016/j.oraloncology.2014.01.006. Epub 2014 Jan 30.

33.

The Effect of tumor subsite on short-term outcomes and costs of care after oral cancer surgery.

Li R, Fakhry C, Koch WM, Gourin CG.

Laryngoscope. 2013 Jul;123(7):1652-9. doi: 10.1002/lary.23952. Epub 2013 May 17.

PMID:
23686386
34.

Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract.

Bishop JA, Ogawa T, Stelow EB, Moskaluk CA, Koch WM, Pai SI, Westra WH.

Am J Surg Pathol. 2013 Jun;37(6):836-44. doi: 10.1097/PAS.0b013e31827b1cd6.

35.

Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study.

Roh JL, Wang XV, Manola J, Sidransky D, Forastiere AA, Koch WM.

Clin Cancer Res. 2013 May 1;19(9):2528-40. doi: 10.1158/1078-0432.CCR-12-3047. Epub 2013 Feb 26.

36.

Distinct epidemiologic characteristics of oral tongue cancer patients.

Li R, Koch WM, Fakhry C, Gourin CG.

Otolaryngol Head Neck Surg. 2013 May;148(5):792-6. doi: 10.1177/0194599813477992. Epub 2013 Feb 8.

PMID:
23396594
37.

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.

Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.

Am J Surg Pathol. 2012 Dec;36(12):1874-82. doi: 10.1097/PAS.0b013e318265fb2b.

38.

Transcervical approach to benign parapharyngeal space tumors.

Chang SS, Goldenberg D, Koch WM.

Ann Otol Rhinol Laryngol. 2012 Sep;121(9):620-4.

PMID:
23012902
39.

Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up.

Koch WM.

Otolaryngol Clin North Am. 2012 Aug;45(4):779-93. doi: 10.1016/j.otc.2012.04.004. Review.

PMID:
22793852
40.

Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas.

Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW Jr, Patton LL, Perkins D, Reid BC, Sciubba JJ, Tomar SL, Wyatt AD Jr, Aravamudhan K, Frantsve-Hawley J, Cleveland JL, Meyer DM; American Dental Association Council on Scientific Affairs Expert Panel on Screening for Oral Souamous Cell Carcinomas.

Tex Dent J. 2012 May;129(5):491-507.

PMID:
22779205
41.

The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.

Roh JL, Ko JH, Moon SJ, Ryu CH, Choi JY, Koch WM.

Cancer Lett. 2012 Dec 1;325(1):35-41. doi: 10.1016/j.canlet.2012.05.020. Epub 2012 May 22.

PMID:
22634494
42.

Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.

Ogawa T, Liggett TE, Melnikov AA, Monitto CL, Kusuke D, Shiga K, Kobayashi T, Horii A, Chatterjee A, Levenson VV, Koch WM, Sidransky D, Chang X.

Cell Cycle. 2012 Apr 15;11(8):1656-63. doi: 10.4161/cc.20120. Epub 2012 Apr 15.

43.

Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes.

Loyo M, Schussel J, Colantuoni E, Califano J, Brait M, Kang S, Koch WM, Sidransky D, Westra WH, Taube JM.

Br J Cancer. 2012 Mar 27;106(7):1314-9. doi: 10.1038/bjc.2012.73. Epub 2012 Mar 13.

44.

Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.

Sun W, Zaboli D, Wang H, Liu Y, Arnaoutakis D, Khan T, Khan Z, Koch WM, Califano JA.

Clin Cancer Res. 2012 Feb 15;18(4):1082-91. doi: 10.1158/1078-0432.CCR-11-2392. Epub 2012 Jan 6.

45.

Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma.

Roh JL, Westra WH, Califano JA, Sidransky D, Koch WM.

Head Neck. 2012 Nov;34(11):1529-36. doi: 10.1002/hed.21982. Epub 2012 Jan 3.

46.

Prospective randomized trial of high versus low negative pressure suction in management of chyle fistula after neck dissection for metastatic thyroid carcinoma.

Wu G, Chang X, Xia Y, Huang W, Koch WM.

Head Neck. 2012 Dec;34(12):1711-5. doi: 10.1002/hed.21979. Epub 2011 Dec 16.

PMID:
22180331
47.

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.

Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN.

Science. 2011 Aug 26;333(6046):1154-7. doi: 10.1126/science.1206923. Epub 2011 Jul 28.

48.

Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care.

Gourin CG, Forastiere AA, Sanguineti G, Marur S, Koch WM, Bristow RE.

Laryngoscope. 2011 Apr;121(4):746-52. doi: 10.1002/lary.21456.

49.

Volume-based trends in surgical care of patients with oropharyngeal cancer.

Gourin CG, Forastiere AA, Sanguineti G, Marur S, Koch WM, Bristow RE.

Laryngoscope. 2011 Apr;121(4):738-45. doi: 10.1002/lary.21457. Epub 2011 Mar 10.

PMID:
21394725
50.

Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care.

Gourin CG, Forastiere AA, Sanguineti G, Koch WM, Marur S, Bristow RE.

Laryngoscope. 2011 Jan;121(1):85-90. doi: 10.1002/lary.21348. Erratum in: Laryngoscope. 2011 Feb;121(2):457.

PMID:
21181983

Supplemental Content

Support Center